Price T Rowe Associates Inc Tyra Biosciences, Inc. Transaction History
Price T Rowe Associates Inc
- $883 Billion
- Q2 2025
A detailed history of Price T Rowe Associates Inc transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 12,022 shares of TYRA stock, worth $166,865. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,022Holding current value
$166,865% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TYRA
# of Institutions
120Shares Held
59.8MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA12.2MShares$169 Million2.55% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$56.6 Million93.82% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$56.3 Million7.35% of portfolio
-
Nextech Invest Ag4.06MShares$56.3 Million10.51% of portfolio
-
Bvf Inc San Francisco, CA3.94MShares$54.7 Million1.48% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $583M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...